Hypertension - Nursing Case Study

Pathophysiology

• Primary mechanism: Increased systemic vascular resistance, often due to arterial wall thickening and reduced elasticity, leads to sustained elevated blood pressure as the heart must exert more force to circulate blood.

• Secondary mechanism: Dysregulation of the renin-angiotensin-aldosterone system (RAAS) results in excessive vasoconstriction and sodium retention, further raising blood volume and pressure.

• Key complication: Prolonged hypertension can cause damage to vital organs, such as the heart (leading to left ventricular hypertrophy), kidneys (resulting in nephropathy), and brain (increasing risk of stroke).

Patient Profile

Demographics:

55-year-old male, office manager

History:

• Key past medical history: Hypertension diagnosed 5 years ago, hyperlipidemia

• Current medications: Lisinopril 20 mg daily, Atorvastatin 10 mg daily

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Persistent headache and dizziness

• Key symptoms: Fatigue, blurred vision, shortness of breath on exertion

• Vital signs: Blood pressure 160/100 mmHg, heart rate 90 bpm, respiratory rate 22 breaths per minute, temperature 98.6°F

Section 1

Change in Patient Status:

During a follow-up visit three weeks after the initial presentation, the patient reports worsening symptoms, including increased fatigue and more frequent episodes of blurred vision. He also notes experiencing swelling in his lower extremities, particularly noticeable at the end of the day. Upon examination, his blood pressure now reads 170/105 mmHg, despite adherence to his current medication regimen. His heart rate remains steady at 88 bpm, but his respiratory rate has increased slightly to 24 breaths per minute. Upon auscultation, there is a noticeable S4 heart sound, suggestive of left ventricular hypertrophy due to the prolonged hypertension.

In response to these changes, the healthcare provider orders a series of diagnostic tests to evaluate potential target organ damage. Blood tests reveal elevated creatinine levels, indicating a decline in renal function, with a creatinine value of 1.8 mg/dL compared to a baseline of 1.2 mg/dL from six months prior. Urinalysis results show microalbuminuria, suggesting early nephropathy. An echocardiogram confirms the presence of left ventricular hypertrophy. These findings highlight the impact of poorly controlled hypertension on both cardiac and renal systems, necessitating a reassessment of the current treatment plan and consideration of additional therapeutic interventions to prevent further complications.

The patient's clinical status underscores the importance of effective blood pressure management and the need for a multidisciplinary approach to address the underlying causes and mitigate the risk of further end-organ damage. The healthcare provider contemplates adjusting the antihypertensive regimen, potentially incorporating a diuretic to alleviate fluid retention and improve blood pressure control. Additionally, patient education on lifestyle modifications, including dietary changes and regular physical activity, becomes a critical component of the care plan to enhance long-term outcomes. The evolving clinical picture prompts the healthcare team to schedule closer monitoring and follow-up to evaluate the response to these interventions.

Section 2

Two weeks after the adjustments to his treatment plan, the patient returns for a follow-up visit. He reports some improvement in his swelling, though he still experiences fatigue and occasional blurred vision. His blood pressure has decreased to 158/98 mmHg, showing a modest response to the addition of a diuretic. However, new concerns arise as he begins to describe episodes of dizziness, particularly when standing up quickly. Upon examination, his heart rate is slightly elevated at 94 bpm, and his respiratory rate remains steady at 22 breaths per minute. Physical examination reveals persistent pitting edema in the lower extremities, and an S4 heart sound is still present, suggesting ongoing strain on the heart.

The healthcare provider orders repeat blood tests to monitor renal function and assess electrolyte balance, given the introduction of the diuretic. The results indicate stable creatinine levels at 1.8 mg/dL, but there is a new finding of mild hypokalemia, with a potassium level of 3.3 mEq/L. This electrolyte imbalance could be contributing to the patient's dizziness and requires prompt attention. The urinalysis continues to show microalbuminuria, confirming that renal stress persists. These findings highlight the need for further adjustment of the treatment strategy, emphasizing careful management of electrolyte levels while striving for optimal blood pressure control.

Considering these developments, the healthcare team decides to modify the patient's medication regimen by introducing a potassium-sparing diuretic or potassium supplements to address the hypokalemia. They also revisit lifestyle recommendations, emphasizing the importance of dietary potassium intake, adequate hydration, and gradual position changes to prevent orthostatic hypotension. The patient is advised to return for another follow-up in two weeks to reassess his response to these interventions and ensure that blood pressure and electrolyte levels are well-managed, aiming to prevent further complications and improve overall health outcomes.

Section 3

Two weeks later, the patient returns for his follow-up appointment. He reports feeling slightly better overall, noting that the dizziness has decreased since the introduction of the potassium-sparing diuretic, and he has been adhering to dietary recommendations to increase his potassium intake. However, he still experiences fatigue and occasional blurred vision, raising concerns about ongoing blood pressure management and potential complications. During the assessment, his blood pressure is measured at 150/92 mmHg, showing a slight improvement but still not at target levels. His heart rate is now 88 bpm, and his respiratory rate holds steady at 22 breaths per minute. The persistent pitting edema in his lower extremities remains unchanged, and the S4 heart sound continues to be present.

New diagnostic results reveal that his potassium level has improved to 3.8 mEq/L, indicating a positive response to the recent modifications in his medication regimen. However, repeat urinalysis shows an increase in microalbuminuria, suggesting that renal stress continues and may be worsening. This raises concerns about the progression of chronic kidney disease, necessitating further evaluation and potential referral to a nephrologist. Additionally, a repeat ECG is performed, revealing left ventricular hypertrophy, which may explain the persistent S4 heart sound and underscores the importance of achieving better blood pressure control to reduce cardiac strain.

The healthcare team discusses these findings with the patient, emphasizing the need for continued adherence to his treatment plan and lifestyle modifications. They highlight the importance of medication compliance, regular monitoring of blood pressure at home, and following dietary recommendations. Given the increase in microalbuminuria and evidence of left ventricular hypertrophy, the team decides to adjust the patient's antihypertensive regimen by adding an ACE inhibitor, aiming to provide renal protection and improve cardiac function. The patient is scheduled for another follow-up in four weeks to monitor his response to these changes and assess for any further complications or necessary adjustments in his care plan.

Section 4

Four weeks later, the patient returns for his follow-up appointment, eager to discuss his progress and any persisting issues. He reports that since the addition of the ACE inhibitor to his treatment plan, he has noticed a modest improvement in his overall energy levels and a reduction in episodes of blurred vision. However, he expresses concern about a new development: occasional dry cough, which he believes may be related to his new medication. Despite this, he remains committed to adhering to his medication regimen and dietary recommendations.

During the assessment, his blood pressure has improved to 142/86 mmHg, indicating better control but still not reaching the optimal target. His heart rate is slightly elevated at 92 bpm, and his respiratory rate remains unchanged at 22 breaths per minute. Although the pitting edema in his lower extremities persists, there is a slight reduction in its severity. The S4 heart sound is still present, confirming ongoing cardiac strain. A repeat urinalysis shows a slight decrease in microalbuminuria, suggesting a potential benefit from the ACE inhibitor, but the levels are still concerning. Additionally, a new set of labs reveals a slight increase in serum creatinine to 1.4 mg/dL, raising questions about the balance between renal protection and potential renal impairment.

The healthcare team reviews these findings with the patient, ensuring he understands the possible side effects of the ACE inhibitor, including the dry cough, and discusses the need for ongoing monitoring of kidney function. They emphasize the importance of continued blood pressure management and consider the potential need for further medication adjustments if the current regimen does not achieve the desired outcomes. The patient is advised to continue monitoring his blood pressure at home and to report any new symptoms promptly. With careful observation and timely interventions, the team aims to prevent further complications and support the patient in achieving optimal health outcomes.

Section 5

Two weeks after the follow-up appointment, the patient contacts the clinic with concerns about increased shortness of breath and fatigue, particularly during mild exertion. He reports experiencing these symptoms more frequently over the past several days. During a home blood pressure check, he notes his readings have increased slightly, averaging around 148/90 mmHg. Alarmed by these changes, he visits the clinic for an urgent evaluation.

Upon assessment, the patient's blood pressure is recorded at 150/92 mmHg, and his heart rate has increased to 98 bpm. His respiratory rate has also risen to 24 breaths per minute, and there is a noticeable audible wheeze upon auscultation. The pitting edema in his lower extremities appears more pronounced, suggesting worsening fluid retention. Additionally, jugular venous distention is observed, raising concerns about potential heart failure exacerbation. The healthcare provider orders a set of labs and an ECG to explore these new symptoms further.

The laboratory results reveal a slight increase in serum creatinine to 1.6 mg/dL, suggesting worsening renal function. BNP levels are elevated at 480 pg/mL, indicative of cardiac stress and possible heart failure. The ECG shows signs of left ventricular hypertrophy and strain patterns, consistent with the ongoing cardiac workload. With these findings, the healthcare team discusses the potential need to adjust the patient's medication regimen, particularly considering the risk of further renal impairment. They emphasize the importance of addressing these complications promptly to prevent further deterioration, and a referral to a cardiologist is considered for more specialized management.